Related Experiment Video
Updated: May 20, 2025

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Embolization management of post-traumatic hepatic pseudoaneurysm: A compelling case report
Hiba Ben Hassine1, Ahmed Hadj Tayeb1, Maissa Jalleli1
1Department of Visceral Surgery, Fattouma Bourguiba Hospital, Monastir, Tunisia.
Abstract:
Pseudoaneurysm of the hepatic artery, first described by Sandblom in 1948, is an uncommon complication of hepatic trauma. Since then, numerous cases have been documented. Post-traumatic hepatic pseudoaneurysm of the hepatic artery is a rare complication, occurring in approximately 1.2% of patients with traumatic liver injury. We report the case of a 25-year-old patient with a history of Behçet's disease, treated with colchicine, who sustained a traffic accident resulting in hepatic contusion and rib fractures. The patient developed right hypochondriac pain, jaundice, and gastrointestinal hemorrhage, consistent with Quincke's triad, suggesting pseudoaneurysm rupture. The diagnosis was confirmed by computed tomography (CT), and the patient underwent successful percutaneous embolization. Despite established guidelines for managing blunt abdominal trauma, the approach to post-traumatic hepatic pseudoaneurysm remains controversial. While some advocate for prophylactic angiographic embolization to prevent bleeding, others favor conservative management due to the potential for spontaneous resolution. Currently, minimally invasive percutaneous embolization is the primary treatment modality. In cases where embolization fails, a transhepatic approach may serve as an alternative. The angioscan is a reliable diagnostic tool. Management is now predominantly minimally invasive, guided by radiological imaging. When conventional angiographic treatment fails, the transhepatic approach can be considered.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

